Skip to content
← Holders

venBio Partners LLC

What venBio Partners LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1776382 · Filed Nov 16, 2026

Positions
9
Reported value
$495.9M
Opened
3
Closed
1
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$176.4M
    6 positions
  2. Dec 31, 2025$216.3M
    6 positions
  3. Mar 31, 2026$280.6M
    6 positions
  4. Jun 30, 2026$519.4M
    7 positions
  5. Sep 30, 2026$495.9M
    9 positions
SecuritySharesChangeValueOf portfolio
PBLSParabilis Medicines, Inc.
5.3M±0%$170.1M34.3%
PHVSPharvaris N.V.
4.5M−4.0%$141.4M28.5%
ATTOAttovia Therapeutics, Inc.
4.2MNew$71.7M14.5%
ACHVAchieve Life Sciences, Inc.
5.9M±0%$47.9M9.6%
ALMSAlumis Inc.
4.2M−7.4%$31M6.2%
ALXOALX Oncology Holdings Inc
12.9M±0%$17.9M3.6%
YARWYarrow Bioscience, Inc.
554.8KNew$12.5M2.5%
LYELLyell Immunopharma, Inc.
337.7K±0%$3.3M0.7%
LSTALisata Therapeutics, Inc.
156.5KNew$225.3K0.1%